Dapoxetine, a drug developed to prevent premature ejaculation, has been given a positive report by a University of Michigan study.
Previously, premature ejaculation was treated with an eclectic mix of therapies, including presenting the sufferer with a decreasingly ugly array of sexual partners. The Kenosha Project, as it was called, often took up to seven years before an ordinary P.E. victim could be expected to not pop in his board shorts at the appearance of a partner reasonably attractive to him.
Sometimes premature ejaculation was so acute among certain test subjects that the first three or four partners would include wombats, wire mesh paper clip holders, and frisbees before eventually moving on to the type of hookers one finds along E. 12th Street in Austin, TX.
Dapoxetine, or Mother’s New Little Helper, is technically an antidepressant that was found to lengthen the maintenance of erections from under 30 seconds to over three minutes.
Previously: Industry fearful of Brazil twink dominance
See also: Premature Ejaculation Drug Hope
Ironically though, given it could take a couple of years for the drug be allowed for use, it appears they’ve announced the news too early.